Bellvitge translational imaging biomarkers group (TRIBIO)

Nahum Calvo Malvar / Montserrat Cortés Romera

PRINCIPAL INVESTIGATORS
  • Gabriel Reynés Llompart
  • Marina Suárez Piñera
CLINICAL RESEARCHERS
  • María Esther Alba Rey
  • Viviana Andreina Carrero Vasquez
  • Josep Castell Aulet
  • Óscar Chirife Chaparro
  • Maria Àngels De Miquel Miquel
  • Miguel Angel Gonzalez Sanchez
  • Laura Maria Gracia Sanchez
  • Juan Jose Martín Marcuartu
  • Pablo Naval Baudín
  • Michal Pudis
  • Javier Jesus Robles Barba
  • Laura Rodríguez Bel
  • Iván Ernesto Sánchez Rodríguez
  • Jose Luis Vercher Conejero
POSTDOCTORAL RESEARCHERS
  • Maria Teresa Bajen Lazaro
  • Ana Benitez Segura
  • Ignacio Martinez Zalacain
  • Paloma Mora Montoya
PREDOCTORAL RESEARCHERS
  • Clemente García Hidalgo
SCIENTIFIC SUPPORT
  • Alvaro Espigares Santiago
  • Mar Gonzalez Montesinos
  • David Llopis González
  • Nancy Karina Sosa Maldonado
MANAGEMENT SUPPORT
  • Eva Orive Romero
Translational Medicine
Digestive system, diagnostics, pharmacogenetics, care support and clinical prevention

Scientific production

30

PAPERS

Average IF: 4,99

2

LED PAPERS

Average IF: 3,55

9 PUBLICATIONS IN FIRST DECILE

15 PUBLICATIONS IN FIRST QUARTILE

23 PUBLICATIONS IN OPEN ACCESS

Selected publications

  • Serra Blasco,M;Miquel Giner,N;Vicent Gil,M;Porta Casteràs,D;Martínez Zalacaín,I;Cano,M;De la Peña Arteaga,V et al, Clinical and Neuroimaging Effects of Mindfulness-Based Cognitive Therapy for Symptomatic Obsessive-Compulsive Disorder Patients after First-Line Treatments: A Randomised Controlled Trial., Psychother Psychosom, 2025;1-17, doi:10.1159/000548961
  • Radua,J;Savage,HS;Vilajosana,E;Jamieson,A;Abler,B;,ÅHSF;Beckers,T et al, Neural correlates of human fear conditioning and sources of variability in 2199 individuals., Nat. Commun., 2025;16(1):7869-7869, doi:10.1038/s41467-025-63078-x
  • Fanti,S;Robles Barba,JJ;Behr,S;Maurer,T;Paredes,P;Walz,J;Duch,J et al, Imaging Efficacy of [(18)F]CTT1057 PET/CT in Patients with Biochemically Recurrent Prostate Cancer: Results from GuidePath-A Phase 3, Prospective Multicenter Study., J Nucl Med, 2025;124(8):1210-1216, doi:10.2967/jnumed.124.269266
  • Ortega Gutierrez,S;Rodriguez Calienes,A;Pujara,D;Sitton,C;Galecio Castillo,M;Hassan,AE;Abraham,MG et al, Endovascular Thrombectomy for Extracranial Internal Carotid Artery Occlusions With Large Ischemic Strokes, Neurology, 2025;104(4):doi:10.1212/WNL.0000000000210269
  • Lapeña,P;Urra,X;Llopis,J;Hernández Meneses,M;Cuervo,G;Maisterra,O;Escrihuela Vidal,F et al, Efficacy and safety of mechanical thrombectomy in acute ischaemic stroke secondary to infective endocarditis., Clin Microbiol Infect, 2025;31(8):1321-1329, doi:10.1016/j.cmi.2025.02.008

Research highlights

PROJECTS

2 Ongoing competitive projects

2 Started clinical trials
5 Ongoing clinical trials

PUBLISHED WORKS

1 Clinical guideline

NETWORKS

SENR

Selected projects

  • CAAA405A12301. Estudio de fase III para evaluar la capacidad diagnóstica de la PET con [18F]-CTT1057 en pacientes con cáncer de próstata con aumento de los niveles del PSA (Recurrencia Bioquímica [RB]) (GUIDEPATH). Novartis Farmacéutica, S.A. Budget: 148.523€. 2021- . PI: JAVIER JESÚS ROBLES BARBA.
  • CI24-10486. MSPredict: MS Prognosis through Advanced Imaging Analysis. FUNDACIÓ “LA CAIXA”. Budget: 50.000€. 2024-2026. PI: PABLO NAVAL BAUDÍN.
  • SEMNIM. Estudio dosimétrico en los pacientes tratados con [177Lu]Lu-PSMA-617. Sociedad Española de Medicina Nuclear e Imagen Molecular (SEMNIM). Budget: 25.000€. 2023-2025. PI: JUAN JOSE MARTÍN MARCUARTU.
  • OSPREY01. ONCOSIL PANCREATIC CANCER POST-MARKETING CLINICAL REGISTRY. OncoSil Medical Ltd. Budget: 9.660€. 2024- . PI: JUAN JOSE MARTÍN MARCUARTU.
  • MOTION CORRECTION TECHNIQUES IN LUNG PET/MR IMAGING, RADIOMICS FEATURE EXTRACTION AND COMPARISON WITH GOLD STANDARD PET/CT. GE Healthcare España, S.A. 2025- . PI: MONTSERRAT CORTÉS ROMERA/JOSÉ LUIS VERCHER CONEJERO/GABRIEL REYNÉS LLOMPART.